Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant content changes detected between the old and new page; core study details, eligibility criteria, outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:15:03.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    5%
    Check dated 2025-10-05T10:12:39.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:13:00.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing the previous v3.0.1; the Back to Top element has been removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-13T16:59:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T14:30:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name, location details, and a list of publications related to a specific clinical study, while removing outdated location terms and references to certain diseases.
    Difference
    16%
    Check dated 2025-08-30T11:18:55.000Z thumbnail image

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.